October brought several updates in the lung cancer field, ranging from notable trial results to patient-centered perspectives ...
CureWise, the AI-powered platform Steve originally developed to help with his own rare blood cancer diagnosis, has evolved ...
The FDA approved Darzalex Faspro for the treatment of adults with high-risk smoldering multiple myeloma. The U.S. Food and ...
Jeannine Walston has a survivorship story of more than 25 years to share. Walston, who has contributed to CURE as a blogger ...
Steve Brown and Lisa Booth sat down for a joint interview with CURE to discuss the future of patient-driven artificial intelligence in cancer care.
Amtagvi monotherapy achieved a 25.6% objective response rate and 71.8% disease control rate in NSCLC patients without ...
Throughout October, CURE highlighted research developments and evolving treatment strategies that continue to shape cancer ...
Steve Brown and Lisa Booth sat down for a joint interview with CURE to discuss the future of patient-driven artificial intelligence in cancer care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback